| Cross talk pathways between coagulation and inflammation JH Foley, EM Conway Circulation research 118 (9), 1392-1408, 2016 | 517 | 2016 |
| Complement activation in arterial and venous thrombosis is mediated by plasmin JH Foley, BL Walton, MM Aleman, AM O'Byrne, V Lei, M Harrasser, ... EBioMedicine 5, 175-182, 2016 | 129 | 2016 |
| Insights into thrombin activatable fibrinolysis inhibitor function and regulation JH Foley, PY Kim, NJ Mutch, A Gils Journal of Thrombosis and Haemostasis 11, 306-315, 2013 | 129 | 2013 |
| Fibrinogen as a hemostatic agent B Sørensen, OH Larsen, CJ Rea, M Tang, JH Foley, C Fenger-Eriksen Seminars in thrombosis and hemostasis, 268-273, 2012 | 95 | 2012 |
| Hi‐Fi SELEX: a high‐fidelity digital‐PCR based therapeutic aptamer discovery platform E Ouellet, JH Foley, EM Conway, C Haynes Biotechnology and bioengineering 112 (8), 1506-1522, 2015 | 84 | 2015 |
| Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry K Yu, BFL Lai, JH Foley, MJ Krisinger, EM Conway, JN Kizhakkedathu ACS nano 8 (8), 7687-7703, 2014 | 81 | 2014 |
| Polyphosphate suppresses complement via the terminal pathway JM Wat, JH Foley, MJ Krisinger, LM Ocariza, V Lei, GA Wasney, ... Blood, The Journal of the American Society of Hematology 123 (5), 768-776, 2014 | 69 | 2014 |
| Examining coagulation-complement crosstalk: complement activation and thrombosis JH Foley Thrombosis research 141, S50-S54, 2016 | 68 | 2016 |
| Plasmin (ogen) at the nexus of fibrinolysis, inflammation, and complement JH Foley Seminars in thrombosis and hemostasis 43 (02), 135-142, 2017 | 64 | 2017 |
| Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses JH Foley, EA Peterson, V Lei, LW Wan, MJ Krisinger, EM Conway Journal of thrombosis and haemostasis 13 (4), 610-618, 2015 | 50 | 2015 |
| Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial A Niżankowska-Jędrzejczyk, FR Almeida, AA Lowe, A Kania, P Nastałek, ... Journal of Clinical Sleep Medicine 10 (3), 255-262, 2014 | 50 | 2014 |
| Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia M Gissel, T Orfeo, JH Foley, S Butenas Thrombosis research 130 (6), 948-955, 2012 | 45 | 2012 |
| Solulin increases clot stability in whole blood from humans and dogs with hemophilia JH Foley, KU Petersen, CJ Rea, L Harpell, S Powell, D Lillicrap, ... Blood, The Journal of the American Society of Hematology 119 (15), 3622-3628, 2012 | 40 | 2012 |
| Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis JH Foley, P Kim, ME Nesheim Journal of biological chemistry 283 (14), 8863-8867, 2008 | 40 | 2008 |
| Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation ST Abrams, D Su, Y Sahraoui, Z Lin, Z Cheng, K Nesbitt, Y Alhamdi, ... Blood, The Journal of the American Society of Hematology 137 (1), 103-114, 2021 | 39 | 2021 |
| Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A JH Foley, ME Nesheim, GE Rivard, KE Brummel‐Ziedins Haemophilia 18 (3), e316-e322, 2012 | 39 | 2012 |
| Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of … JH Foley, PF Cook, ME Nesheim Journal of Biological Chemistry 286 (22), 19280, 2011 | 39 | 2011 |
| An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma PYG Kim, J Foley, G Hsu, PY Kim, ME Nesheim Analytical biochemistry 372 (1), 32-40, 2008 | 38 | 2008 |
| Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases: TAFIa level in patients with IBD D Owczarek, A Undas, JH Foley, ME Nesheim, K Jabłonski, T Mach Journal of Crohn's and Colitis 6 (1), 13-20, 2012 | 32 | 2012 |
| Soluble thrombomodulin partially corrects the premature lysis defect in FVIII‐deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor JH Foley, ME Nesheim Journal of Thrombosis and Haemostasis 7 (3), 453-459, 2009 | 30 | 2009 |
